Intratumoural plasma cells mediate a pro-inflammatory response to kinase inhibition and successful immune checkpoint blockade therapy in malignant peripheral nerve sheath tumours. Lingo JJ, Reis R, Koyas A, Voigt E, Zacharias ZR, Allamargot C, Hornick EL, Raygoza Garay JA, Kaemmer CA, Elias EC, Jabbari A, Wilhelm CR, Boyden AW, Karandikar NJ, Breheny P, Meyerholz DK, Dodd RD, Houtman JCD, Darbro BW, Quelle DE. EBioMedicine. 2026 Sep;131:106413. doi: 10.1016/j.ebiom.2026.106413. Epub 2026 Aug 1. PMID: 42541926
Modeling pathogenic B cell function in experimental autoimmune encephalomyelitis. Kumar M*, Wilhelm CR*, Boyden AW. J Immunol. 2026 Jul 10;215(7):vkag163. doi: 10.1093/jimmun/vkag163. *contributed equally PMID: 42435354
Suppressive CD8+ T-cells are key cellular mediators of extracorporeal photopheresis. Rogers KJ, Eschbacher KL, Zacharias Z, Kale K, Crawford MP, Knudson CM, Boyden AW, Karandikar KJ. J Clin Apher. 2026 Feb;41(1): Pubmed PMID: 41653030
Myelin-reactive CD8+ T cells influence conventional dendritic cell subsets towards a mature and regulatory phenotype in experimental autoimmune encephalomyelitis. Upadhye M, Wilhelm CR, Rogers KJ, Vemulawada C, Borcherding N, Boyden AW, Legge KL, Karandikar NJ. J Neuroinflamm. 2025 Feb 28; 22, 54. Pubmed PMID: 40022134
Proteolipid Protein-Induced Mouse Model of Multiple Sclerosis Requires B Cell-Mediated Antigen Presentation. Wilhelm CR, Upadhye MA, Eschbacher KL, Karandikar NJ, Boyden AW. J Immunol. 2023 Sep 15;211(6):944-953. doi: 10.4049/jimmunol.2200721.
Novel B cell-dependent multiple sclerosis model using extracellular domains of myelin proteolipid protein. Boyden AW, Brate AA, Karandikar NJ. Sci Rep. 2020 Mar 19;10(1):5011. doi: 10.1038/s41598-020-61928-w.